REGENXBIO to Participate in Stifel 2026 Healthcare Conference
PR Newswire•03/11/2026•07:05 ET
0
Key Highlights
- ➤REGENXBIO (RGNX) will participate in Stifel’s 2026 Healthcare Conference
- ➤Fireside chat scheduled for November 11, 2026, at 9:20 a.m. ET
- ➤Late-stage pipeline includes RGX-202, RGX-121, RGX-111, and ABBV-RGX-314
REGENXBIO to Participate in Stifel 2026 Healthcare Conference PR Newswire
ROCKVILLE, Md., Nov. 3, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the Stifel 2026 Healthcare Conference.
Get started
Create a free account to read the full story.